Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04854850 · ClinicalTrials.gov registry record · NA
Apollo Device for Fatigue in Systemic Sclerosis
A NA study, sponsored by Robyn T. Domsic, MD, MPH.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04854850 is a NA study that has completed, run by Robyn T. Domsic, MD, MPH. The registered enrollment target is 25 participants.
The verdict
NCT04854850, a NA study, has completed, sponsored by Robyn T. Domsic, MD, MPH.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about the effect of Apollo (a vibrating wearable about the side of an Apple Watch) on fatigue, Raynaud symptoms, depression, quality of life, and disease symptoms in patients with systemic sclerosis. SSc patients frequently have fatigue as a characteristic feature of their disease and fatigue negatively impacts quality of life (Haythornthwaite 2003, Richards 2003, Suarez-Almazor 2007, Basta 2017). The prevalence of fatigue among SSc patients is 75%, with 61% ranking fatigue among their top three most distressing complaints. Fatigue is also associated with poor sleep quality, greater pain and depressive symptoms (Sandusky 2009). We hypothesize that treatment with Apollo over 1 month will improve fatigue. If successful, the Apollo technology will be the first treatment option for fatigue and Raynaud's in this population.
Interventions
- DEVICE Apollo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2023-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04854850
The ClinicalTrials.gov registry entry for NCT04854850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Robyn T. Domsic, MD, MPH, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Apollo is the first listed.
NCT04854850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04854850 about?
NCT04854850 is a clinical study titled "Apollo Device for Fatigue in Systemic Sclerosis". The purpose of this study is to learn about the effect of Apollo (a vibrating wearable about the side of an Apple Watch) on fatigue, Raynaud symptoms, depression, quality of life, and disease symptoms in patients with systemic sclerosis. SSc patients frequently have fatigue as a characteristic feat...
What is the current status of trial NCT04854850?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-07-07. Estimated completion is 2023-03-15.
What interventions are being tested in trial NCT04854850?
The interventions under investigation include: Apollo (DEVICE).
Who is sponsoring clinical trial NCT04854850?
This trial is sponsored by Robyn T. Domsic, MD, MPH, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.